Thrombocytopenia during levetiracetam therapy

Epilepsy Res. 2008 Jul;80(1):91-2. doi: 10.1016/j.eplepsyres.2008.03.002.

Abstract

A 64-year-old patient with symptomatic epilepsy developed thrombocytopenia during treatment with levetiracetam (LEV). As no other medical reason could be evaluated, a medication side effect was postulated. The only new drugs were valproic acid (since 3 weeks) and levetiracetam (since 3 days). After valproic acid medication was ended, thrombocytopenia did not improve and even worsened further. Finally levetiracetam administration was ended and trombocytopenia resolved rapidly and completely within few days.

MeSH terms

  • Anticonvulsants / adverse effects*
  • Epilepsy, Complex Partial / drug therapy
  • Female
  • Humans
  • Levetiracetam
  • Middle Aged
  • Piracetam / adverse effects
  • Piracetam / analogs & derivatives*
  • Thrombocytopenia / chemically induced*

Substances

  • Anticonvulsants
  • Levetiracetam
  • Piracetam